NCT06451874 Personalized Exercise Treatments for Older Veterans With Motoric Cognitive Risk Syndrome
| NCT ID | NCT06451874 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Motoric Cognitive Risk Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2029-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2025-07-01 with a primary completion date of 2029-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g., problems with memory or concentrations).
Eligibility Criteria
Inclusion Criteria: 1. Age 65 2. Receiving VA primary care 3. Community-dwelling 4. Motoric Cognitive Risky Syndrome i. Slow gait speed ii. Subjective cognitive concerns/complaints Exclusion Criteria: 1. Non-English speaking 2. Presence of a terminal disease 3. Major medical problem 4. Myocardial infarction or major surgery in the previous 3 months 5. 3-point walking pattern 6. Dementia diagnostic 7. Mobility disability
Contact & Investigator
Elisa Ogawa, PhD MS BS
PRINCIPAL INVESTIGATOR
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Frequently Asked Questions
Who can join the NCT06451874 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Motoric Cognitive Risk Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06451874 currently recruiting?
Yes, NCT06451874 is actively recruiting participants. Contact the research team at elisa.ogawa@va.gov for enrollment information.
Where is the NCT06451874 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06451874 clinical trial?
NCT06451874 is sponsored by VA Office of Research and Development. The principal investigator is Elisa Ogawa, PhD MS BS at VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA. The trial plans to enroll 54 participants.